Stay updated on KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page.

Latest updates to the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page
- CheckyesterdayChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference1%
- Check8 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest has been deleted.SummaryDifference1%
- Check15 days agoChange DetectedDifference0.2%
- Check22 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.9%
- Check29 days agoChange DetectedDifference0.2%
- Check36 days agoChange DetectedThe web page has been updated from version v2.16.1 to v2.16.2.SummaryDifference0.2%
Stay in the know with updates to KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page.